BiotechTube
Home/Magenta Therapeutics/Michael A. Narachi
MA

Michael A. Narachi

Former Chairman of the Board

Magenta Therapeutics

Therapeutic Areas

Autoimmune DiseasesBlood CancersGenetic Diseases

Magenta Therapeutics Pipeline

DrugIndicationPhase
MGTA-117Conditioning for AML/MDS transplantPhase 1/2
MGTA-145 + plerixaforStem cell mobilizationPhase 2

Leadership Team at Magenta Therapeutics

JG
Jason Gardner, D.Phil.
Co-founder, President & CEO
MB
Michael Bell, Ph.D.
Co-founder, former CSO
View full Magenta Therapeutics profile